FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Akorn Myorisan Recall

MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Pres…

Akorn, Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Jan 8, 2020
Recall ID
D-0647-2020
Check your lot numberHow we source this data

Summary

Akorn recalled Myorisan starting Nov 15, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0647-2020 on Jan 8, 2020. Reason: Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product. Status: Terminated.

Why it was recalled

Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product.

Product description

MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Prescription Packs) per box, Rx only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forset, IL 60045; NDC 61748-302-13.

Lot numbers, UPCs & expiration codes

Lot V20M54A, Exp 01/2021

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0647-2020
Classification
Class II
Status
Terminated
Recall initiated
Nov 15, 2019
FDA report date
Jan 8, 2020
Quantity
4,206 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-0647-2020, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
84261
Address
1925 W Field Ct Ste 300
Code information
Lot V20M54A, Exp 01/2021
Postal code
60045-4862
Report date
Jan 8, 2020
Product type
Drugs
Recall number
D-0647-2020
Classification
Class II
Recalling firm
Akorn, Inc.
Product quantity
4,206 boxes
Termination date
Aug 9, 2022
Reason for recall
Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Prescription Packs) per box, Rx only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forset, IL 60045; NDC 61748-302-13.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Nov 15, 2019
Initial firm notification
Letter
Center classification date
Jan 6, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0647-2020, published Jan 8, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls